MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
39 hedge funds and large institutions have $37.3M invested in Merrimack Pharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
69% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 13
74% less call options, than puts
Call options by funds: $215K | Put options by funds: $839K
Holders
39
Holding in Top 10
1
Calls
$215K
Puts
$839K
Top Buyers
| 1 | +$638K | |
| 2 | +$116K | |
| 3 | +$24K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$3.25K |
| 5 |
OSAM
O'Shaughnessy Asset Management
Stamford,
Connecticut
|
+$84 |
Top Sellers
| 1 | -$689K | |
| 2 | -$267K | |
| 3 | -$250K | |
| 4 |
Renaissance Technologies
New York
|
-$191K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$88.3K |